Infusion pump

Smiths Medical Announces the ECRI Evaluation of the CADD®-Solis v4 Wireless Ambulatory Infusion System

Retrieved on: 
Tuesday, March 30, 2021

Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.

Key Points: 
  • Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.
  • View the full release here: https://www.businesswire.com/news/home/20210330005181/en/
    CADD-Solis v4 with wireless communications Patient-Controlled Analgesic (PCA) and epidural infusion pump.
  • (Photo: Business Wire)
    The CADD-Solis v4 system is a continuation of Smiths Medicals commitment to advance patient care and help improve patient outcomes through leading-edge technology.
  • Smiths Medical is committed to patient safety and adoption of smart infusion pumps, said Nathan Walker, Director of Ambulatory Infusion at Smiths Medical.

Starton Therapeutics Completes Pre-IND Meeting with FDA: Clearing Path to Phase 1 Clinical Study for STAR-LLD Continuous Infusion

Retrieved on: 
Monday, March 22, 2021

The Companys target initiation of a Phase 1 clinical study in Q4-2021 remains on track.

Key Points: 
  • The Companys target initiation of a Phase 1 clinical study in Q4-2021 remains on track.
  • Starton will incorporate the FDAs recommendations and does not expect any impact on the timing of the proposed STAR-LLD clinical program.
  • Startons proposed animal safety study was acceptable to the FDA and Starton expects to complete the nonclinical requirements for the IND submission in Q3-2021.
  • STAR-LLD SC is a continuous subcutaneous infusion of lenalidomide parenteral solution via an infusion pump.

Eitan Medical Receives EU MDR Clearance for Sapphire™ Infusion System

Retrieved on: 
Tuesday, March 9, 2021

NETANYA, Israel, March 9, 2021 /PRNewswire/ -- Eitan Medical , a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that its Sapphire infusion pump, accessories, and administration sets, have received EU Medical Device Regulation (MDR) 2017/45 certification.

Key Points: 
  • NETANYA, Israel, March 9, 2021 /PRNewswire/ -- Eitan Medical , a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that its Sapphire infusion pump, accessories, and administration sets, have received EU Medical Device Regulation (MDR) 2017/45 certification.
  • "This is an important milestone for Eitan Medical, representing our commitment to meeting the most stringent regulatory requirements.
  • Eitan Medical's Sapphire infusion system serves clinicians in hospitals and home care environments across Europe.
  • Eitan Medical, Sapphire, Avoset, and Sorrel are trademarks or registered trademarks of Eitan Medical.

Eitan Medical Receives EU MDR Clearance for Sapphire™ Infusion System

Retrieved on: 
Tuesday, March 9, 2021

NETANYA, Israel, March 9, 2021 /PRNewswire/ -- Eitan Medical , a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that its Sapphire infusion pump, accessories, and administration sets, have received EU Medical Device Regulation (MDR) 2017/45 certification.

Key Points: 
  • NETANYA, Israel, March 9, 2021 /PRNewswire/ -- Eitan Medical , a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that its Sapphire infusion pump, accessories, and administration sets, have received EU Medical Device Regulation (MDR) 2017/45 certification.
  • "This is an important milestone for Eitan Medical, representing our commitment to meeting the most stringent regulatory requirements.
  • Eitan Medical's Sapphire infusion system serves clinicians in hospitals and home care environments across Europe.
  • Eitan Medical, Sapphire, Avoset, and Sorrel are trademarks or registered trademarks of Eitan Medical.

Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances

Retrieved on: 
Wednesday, March 3, 2021

As Senior VP, Drug Delivery, Moberg will lead the development of Bexson's drug delivery technologies, starting with a wearable infusion device for its BB106 therapy, in partnership with Italian drug containment solution and medical device manufacturer, Stevanato Group.

Key Points: 
  • As Senior VP, Drug Delivery, Moberg will lead the development of Bexson's drug delivery technologies, starting with a wearable infusion device for its BB106 therapy, in partnership with Italian drug containment solution and medical device manufacturer, Stevanato Group.
  • Moberg brings 30+ years of expertise to Bexson, combining medical device innovation with a deep understanding of combination product development programs.
  • With the addition of Moberg, Bexson is expanding its drug delivery program to develop solutions for other drug therapies, where subcutaneous delivery and dosing control provide distinct advantages.
  • Controlled delivery with a wearable pump can help solve limitations in dosing profile, bioavailability, pharmacokinetics, diversion risk and GI side effects.

Worldwide Patient Controlled Injectors Industry to 2027 - Technological Advancements and Design Development Presents Opportunities

Retrieved on: 
Wednesday, February 10, 2021

According to this report the global patient controlled injectors market is expected to reach $2,969.47 million by 2027 from $7,505.70 million in 2019.

Key Points: 
  • According to this report the global patient controlled injectors market is expected to reach $2,969.47 million by 2027 from $7,505.70 million in 2019.
  • The report highlights trends prevailing in the global patient controlled injectors market and the factors driving market along with those that act as hindrances.
  • Based on product, the global patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps.
  • The growth of the patient controlled injectors market is attributed to the factors such as increasing prevalence of chronic conditions and acceptance of patient controlled injectors due to better patient compliance.

ICU Medical's Plum 360™ Infusion System Receives First-Ever Best in KLAS Honor as Top-Performing Smart Pump EMR-Integrated

Retrieved on: 
Tuesday, February 2, 2021

The award is a new category for KLAS, which named the Plum 360 the top-performing IV smart pump in its Best in KLAS: Software & Services report in 2018, 2019 and 2020.

Key Points: 
  • The award is a new category for KLAS, which named the Plum 360 the top-performing IV smart pump in its Best in KLAS: Software & Services report in 2018, 2019 and 2020.
  • "The Best in KLAS report and the awards it contains set the standard of excellence for software and services firms.
  • Dan Woolson, corporate vice president and general manager of ICU Medical Infusion Systems, called Plum 360's award by KLAS as the top-performing interoperable smart pump "significant and a direct reflection of customer success and ICU Medical's leadership in interoperability."
  • Hutchings added that being awarded 2021 Best in KLAS for Smart Pumps EMR-Integrated demonstrates that ICU Medical is a leader in helping health care organizations meet ISMP guidelines, including implementing bidirectional smart infusion pump interoperability with the EMR.

B. Braun Infusomat® Space® Infusion Pump Receives 2021 Best in KLAS Award for Traditional Smart Pumps

Retrieved on: 
Tuesday, February 2, 2021

BETHLEHEM, Pa., Feb. 2, 2021 /PRNewswire/ --B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced its Infusomat Space Large Volume Pump was awarded a 2021 Best in KLAS for Traditional Smart Pumps.

Key Points: 
  • BETHLEHEM, Pa., Feb. 2, 2021 /PRNewswire/ --B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced its Infusomat Space Large Volume Pump was awarded a 2021 Best in KLAS for Traditional Smart Pumps.
  • KLAS President, Adam Gale, said, "The Best in KLAS report and the awards it contains set the standard of excellence for software and services firms.
  • Vendors who win the title of "Best in KLAS" should celebrate and remember that providers now accept only the best from their products and services.
  • B. Braun's Space infusion pumps allow customers to standardize on a single platform for all of their large volume pump, syringe pump, and PCA infusions.

Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet

Retrieved on: 
Tuesday, February 2, 2021

Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics.

Key Points: 
  • Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics.
  • Mindray BeneFusion e Series streamlines workflow via a 3.5" colored capacitive touchscreen, which features an intuitive UI for smooth touch operation.
  • When it comes to efficiency in safety, BeneFusion e Series supports stable and seamless infusions with a smooth automatic multi-channel relay.
  • These infusion systems can be linked to BeneVision CMS, which offers efficient one-stop monitoring of all patients' vital signs and infusion treatment details.

Eitan Medical Receives FDA Clearance for Upgraded Sapphire™ Infusion Pump System

Retrieved on: 
Tuesday, January 19, 2021

NETANYA, Israel, Jan. 19, 2021 /PRNewswire/ -- Eitan Medical , a global leader in advanced infusion therapy and drug delivery solutions across the care continuum,announced today that its upgraded Sapphire infusion pump system software Rev15, which includes the infusion pump, administration sets and accessories, has received US Food and Drug Administration (FDA) 510(k) clearance.

Key Points: 
  • NETANYA, Israel, Jan. 19, 2021 /PRNewswire/ -- Eitan Medical , a global leader in advanced infusion therapy and drug delivery solutions across the care continuum,announced today that its upgraded Sapphire infusion pump system software Rev15, which includes the infusion pump, administration sets and accessories, has received US Food and Drug Administration (FDA) 510(k) clearance.
  • The Sapphire infusion system is the company's flagship infusion device, and is used across the U.S. within alternate sites, homecare markets, emergency medical services (EMS) and hospitals.
  • "For over a decade, the Sapphire infusion pump has established itself as an extremely capable and easy to use across the healthcare continuum.
  • * NRFit is a trademark of B. Braun
    Eitan Medical, Sapphire, Avoset, and Sorrel are trademarks or registered trademarks of Eitan Medical.